Subscribe

Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

IJPPE > Volume 6 > D-002 Ameliorates Histological Changes in Rats...
< Back to Volume

D-002 Ameliorates Histological Changes in Rats with Bile Reflux-Induced Esophagitis

Full Text PDF

Abstract:

Reflux esophagitis, a common gastrointestinal disease, may be induced by duodeno gastroesophageal-reflux, and by duodeno-esophageal reflux (DER), the reflux of the biliary content only. D-002, a mixture of six higher primary alcohols purified from the beeswax, has exhibited gastric and esophageal protection experimentally. The aim of this work was to investigate the effects of D-002 on the esophageal histological changes in rats with DER-induced esophagitis. Rats were randomized into six groups: a negative control and five with DER: a positive control, three D-002- (50, 200 and 400mg/kg, respectively) and one omeprazole (20 mg/kg) group, treated for 14 days. Microscopic studies of esophagus were performed looking for reflux esophagitis indicators, such as basal cell hyperproliferation, papillae elongation, inflammatory cell infiltrates, epithelial erosions and ulcerations. The thickness of esophageal epithelium was measured and leukocytes were counted. Histological characteristics of esophagitis were evaluated. Negative controls had normal esophagus, while positive controls exhibited marked esophagitis. The values of the histological score, thickness of the esophageal epithelium and leukocyte infiltration in the positive control group were higher (p <0.001) than in the negative control. D-002 (50 - 400 mg/kg) reduced significantly (p <0.01) the histological scores versus the positive control group. D-002 lowered significantly the epithelium thickness and abolished (p <0.001) leukocytes infiltration versus the positive control. Compared with the positive control, omeprazole reduced (p <0.01) the histological score, the epithelium thickness and leukocytes infiltration. Repeated doses of D-002 ameliorated the histological changes in rats with DER-induced esophagitis.

Info:

Periodical:
International Journal of Pharmacology, Phytochemistry and Ethnomedicine (Volume 6)
Pages:
72-81
Citation:
M. Noa et al., "D-002 Ameliorates Histological Changes in Rats with Bile Reflux-Induced Esophagitis", International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Vol. 6, pp. 72-81, 2017
Online since:
Jan 2017
Export:
Distribution:
References:

[1] J.Y. Mabrut, J.M. Collard, J. Baulieux, Duodenogastric and gastroesophageal bile reflux, J. Chir. 143(6) (2006) 355-365.

[2] A. Agrawal et al., Symptoms with acid and nonacid reflux may be produced by different mechanisms, Dis. Esophagus. 22 (2009) 467–470.

[3] G. Boeckxstaens et al., Symptomatic reflux disease: the present, the past and the future, Gut. 63(7) (2014) 1185–1193.

[4] S. Jürgens et al., The role of bile acids in the neoplastic progression of Barrett's esophagus - a short representative overview, Z. Gastroenterol. 50 (2012) 1028-1034.

[5] F. Hvid-Jensen et al., Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med. 365 (2011) 1375–1383.

[6] K.R. McQuaid et al., Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia, Aliment. Pharmacol. Ther. 34(2) (2011) 146-165.

[7] Y.J. Kim, E.H. Kim, K.B. Hahm, Oxidative stress in inflammation-based gastrointestinal tract diseases: challenges and opportunities, J. Gastroenterol. Hepatol. 27 (2012) 1004-1010.

[8] K. Dvorak et al., Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus, Gut. 56 (2007) 763–771.

DOI: https://doi.org/10.1136/gut.2006.103697

[9] A.J. Jolly, C.P. Wild, L.J. Hardie. Sodium deoxycholate causes nitric oxide mediated DNA damage in oesophageal cells, Free Radic. Res. 43 (2009) 234–240.

DOI: https://doi.org/10.1080/10715760802684211

[10] J. Theisen et al., The mutagenic potential of duodenoesophageal reflux, Ann Surg. 241 (2005) 63–68.

[11] R. Zhang et al., Bile salts inhibit growth and induce apoptosis of culture human normal esophageal mucosal epithelial cells, World J. Gastroenterol. 11 (2005) 6466–6471.

[12] K. Dvorakova et al., Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues, Am. J. Gastroenterol. 100 (2005) 424–431.

[13] T.K. Desai et al., The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis, Gut. 61 (2012) 970–976.

[14] A. Nakos et al., The histological and immunohistochemical aspects of bile reflux in patients with gastroesophageal reflux disease, Gastroenterol. Res. Pract. 2011 (2011) 1-9.

[15] P.J. Kahrilas, N.J. Shaheen, M.F. Vaezi, American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease, Gastroenterol. 135 (2008) 1392-1413.

[16] D.A. Johnson, B.H. Levy, 3rd Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors, Expert Opinion on Pharmacotherapy. 11(9) (2010) 1541–1548.

[17] J. Venkataraman, A. Krishnan, Long-term medical management of gastro-esophageal reflux disease: how long and when to consider surgery?, Trop. Gastroenterol. 33(1) (2012) 21-32.

[18] S.M. Wilhelm, R.G. Rjater, P.B. Kale-Pradhan, Perils and pitfalls of long-term effects of proton pump inhibitors, Expert Rev. Clin. Pharmacol. 6 (2013) 443-451.

[19] Mas R. D-002: A product obtained from beeswax, Drugs of the Future. 26 (2001) 731-744.

[20] D. Carbajal et al., Anti-ulcer activity of higher primary alcohols of beeswax, J. Pharm. Pharmacol. 47 (1995) 731-733.

[21] D. Carbajal et al., Possible cytoprotective mechanism in rats of D-002 an anti-ulcerogenic product isolated from beeswax, J. Pharm. Pharmacol. 48 (1996) 858-860.

[22] D. Carbajal et al., Effects of D-002 on gastric mucus composition in ethanol-induced ulcer, Pharmacol. Res. 42 (2000) 329-332.

[23] V. Molina et al., Antioxidant effects of D-002 on gastric mucosa of rats with experimentally-induced injury, J. Med. Food. 4 (2001) 79-83.

[24] Y. Pérez et al., Protective effect of D-002, a mixture of beeswax alcohols, against indomethacin-induced gastric ulcers and mechanism of action, J. Nat. Med. 67 (2013) 182-189.

[25] Y. Pérez et al., Inhibition of cyclooxygenase and 5-lipooxygenase enzymes by D-002 (beeswax alcohols). Current Topics in Nutraceuticals Research. 12(1/2) (2014) 13-18.

[26] M. Okazaki et al., Gastric mucosal levels of prostaglandins and leukotrienes in patients with gastric ulcer after treatment with rabeprazole in comparison to treatment with ranitidine, J. Med. Invest. 54 (2007) 83-90.

[27] Z. Zamora et al., Protective effects of D-002 on experimentally induced gastroesophageal reflux in rats, World J. Gastroenterol. 20 (2014) 2085-(2090).

[28] Z. Zamora et al., Effects of D-002 on esophagitis induced by duodenal- esophageal reflux (DER) and duodenogastro-esophageal reflux (DGER) in rats, Int. J. of Pharmacol. Toxicol. 5(3) (2015) 146-151.

[29] N. Inatomi et al., Effects of a proton pump inhibitor, AG-1749 (Lanzoprazole), on reflux esophagitis and experimental ulcers in rats, Japan J. Pharmacol. 55 (1991) 437-451.

[30] N. Hashimoto, Expression of COX2 and p.53 in rat esophageal cancer induced by reflux of duodenal contents, ISRN Gastroenterol. 2012 (2012) 1-5.

[31] Y. Li, R.C. Martin, 2nd Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma, Dis. Esophagus. 20 (2007) 372–378.

[32] H. Aiyer, L. Yan, R. Martin, Diet composition affects surgery-associated weight loss in rats with a compromised alimentary tract, J. Surg. Res. 168 (2011) 42–48.

[33] H.S. Aiyer et al., Dietary freeze dried black raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats, Nutrition. 27 (2011) 182–187.

[34] D. Asaoka et al., Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis, World J. Gastroenterol. 15(28) (2009) 3480–3485.

[35] R.R. Kedika, R.F. Souza, S.J. Spechler, Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications, Digestive diseases and sciences. 54(11) (2009) 2312–2317.

[36] T.Y. Oh et al., Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment, Free Radic Biol Med. 30 (2001) 905-915.

Show More Hide